Cardiac Rhythm Management Devices | Market Insights | US | 2018
The mature US CRM device market will remain flat through 2026, striking a balance between flat generator unit sales, rising ICM procedure volumes, and price erosion. Premium-priced devices such as MRI-compatible devices, leadless pacemakers, and S-ICDs will help mitigate price erosion to a small extent.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the US cardiac rhythm management device market across a 10-year period.